share_log

RBC Capital Initiates Coverage On Sophia Genetics With Outperform Rating, Announces Price Target of $8

RBC Capital Initiates Coverage On Sophia Genetics With Outperform Rating, Announces Price Target of $8

加拿大皇家銀行資本以跑贏大盤的評級啓動對索菲亞遺傳學的報道,宣佈目標股價爲8美元
Benzinga ·  2023/11/29 05:53

RBC Capital analyst Conor McNamara initiates coverage on Sophia Genetics (NASDAQ:SOPH) with a Outperform rating and announces Price Target of $8.

加拿大皇家銀行資本分析師康納·麥克納馬拉以跑贏大盤的評級開始對索菲亞遺傳學(納斯達克股票代碼:SOPH)進行報道,並宣佈目標股價爲8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論